What factors do you look at while deciding between a daratumumab-based quadruplet induction versus standard triplet induction such as VRd for newly diagnosed MM?  


Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Winship Cancer Institute of Emory University
I agree that the benefit of 4-drug induction is mo...
Medical Oncologist at ProMedica Flower Hospital
@Ben Derman, for patients with high risk cytogenet...
Medical Oncologist at University of Chicago
If the patient does not have significant neuropath...
Medical Oncologist at Upper Chesapeake Hematology Oncology
What do you offer for induction for a standard ris...
at The Robert Larner, M.D. College of Medicine at The University of Vermont
@Lillian Man - Yes! The MAIA trial confirms the OS...
Medical Oncologist at Texas Oncology Dallas
What regimen do you favor in someone with newly di...
Sign in or Register to read more

Answer from: at Community Practice